Clinical Trial Update: Systemic Sclerosis Clinical and Biomarker Study

View source ↗

Summary

Biogen's Systemic Sclerosis clinical and biomarker study has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Biogen | Conditions: Healthy, Systemic Sclerosis | Status: WITHDRAWN